Plus Therapeutics Inc

0.00 (+0.46%)
4:43:38 PM EDT: $0.45 +0.02 (+3.87%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)14.58M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.48 Million
Adjusted EPS-$0.15
See more estimates
10-Day MA$0.44
50-Day MA$0.48
200-Day MA$0.67
See more pivots

Plus Therapeutics Inc Stock, NASDAQ:PSTV

4200 Marathon Boulevard, Suite 200, Austin, Texas 78756
United States of America
Phone: +1.737.255.7194
Number of Employees: 14


Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Austin, TX.